$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] Rational Design, Synthesis and Evaluation of Novel C6‐Bicycloalkaneimidazole Containing Imidazo[1,2‐b]pyridazines for ASK1 Inhibition 원문보기

Bulletin of the Korean chemical society, v.42 no.6, 2021년, pp.872 - 877  

Lee, Yujin (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Jang, Jiyoon (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Bibi, Maimoona (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Duggirala, Krishna Babu (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Ji, Sang Hee (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Lee, Ji Hun (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Ahn, Sunjoo (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Song, Jin Sook (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Chae, Chong Hak (Bio and Drug Discovery Division Korea Research Institute of Chemical Technology Daejeon 34114 South Korea) ,  Kim, Seong Hwan (Bio and Drug Discovery Divis) ,  Lee, Kwangho

Abstract AI-Helper 아이콘AI-Helper

Apoptosis signal‐regulating kinase 1 (ASK1) is a member of mitogen‐activated protein kinase kinase kinase (MAP3K) family that involves downstream phosphorylation of MAP kinases, c‐Jun N‐terminal kinases, and p38 MAP kinases. ASK1 inhibitors could possibly be beneficial fo...

참고문헌 (20)

  1. Matsuzawa, Atsushi, Saegusa, Kaoru, Noguchi, Takuya, Sadamitsu, Chiharu, Nishitoh, Hideki, Nagai, Shigenori, Koyasu, Shigeo, Matsumoto, Kunihiro, Takeda, Kohsuke, Ichijo, Hidenori. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nature immunology, vol.6, no.6, 587-592.

  2. Ichijo, Hidenori, Nishida, Eisuke, Irie, Kenji, Dijke, Peter ten, Saitoh, Masao, Moriguchi, Tetsuo, Takagi, Minoru, Matsumoto, Kunihiro, Miyazono, Kohei, Gotoh, Yukiko. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways. Science, vol.275, no.5296, 90-94.

  3. J. Biol. Chem. Matsuzawa A. 1e8 130 2001 

  4. Kefala, Georgia, Tziomalos, Konstantinos. Apoptosis signal-regulating kinase-1 as a therapeutic target in nonalcoholic fatty liver disease. Expert review of gastroenterology & hepatology, vol.13, no.3, 189-191.

  5. 10.1016/bs.pmch.2020.02.001 

  6. Chalasani, Naga, Younossi, Zobair, Lavine, Joel E., Diehl, Anna Mae, Brunt, Elizabeth M., Cusi, Kenneth, Charlton, Michael, Sanyal, Arun J.. The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.55, no.6, 2005-2023.

  7. 10.1111/j.1365-2036.2011.04724.x G.Vernon A.Baranova Z. M.Younossi Aliment Pharmacol. Ther.2011 34 274. 

  8. Zhang, Shiyan, Huang, Chaoying, Lyu, Xilin, Wang, Peipei, Zang, Yi, Wang, Zengtao, Wang, Huan, Li, Jia, Zhao, Yujun. Discovery of a 2-pyridinyl urea-containing compound YD57 as a potent inhibitor of apoptosis signal-regulating kinase 1 (ASK1). European journal of medicinal chemistry, vol.195, 112277-.

  9. Xin, Zhili, Himmelbauer, Martin K., Jones, J. Howard, Enyedy, Istvan, Gilfillan, Rab, Hesson, Thomas, King, Kristopher, Marcotte, Douglas J., Murugan, Paramasivam, Santoro, Joseph C., Gonzalez-Lopez de Turiso, Felix. Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors. ACS medicinal chemistry letters, vol.11, no.4, 485-490.

  10. Lanier, Marion, Pickens, Jason, Bigi, Simone V., Bradshaw-Pierce, Erica L., Chambers, Alison, Cheruvallath, Zacharia S., Cole, Derek, Dougan, Douglas R., Ermolieff, Jacques, Gibson, Tony, Halkowycz, Petro, Hirokawa, Aki, Ivetac, Anthony, Miura, Joanne, Nunez, Evan, Sabat, Mark, Tyhonas, John, Wang, Haixia, Wang, Xiaolun, Swann, Steve. Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure. ACS medicinal chemistry letters, vol.8, no.3, 316-320.

  11. Hou, Shaohua, Yang, Xiping, Tong, Yu, Yang, Yuejing, Chen, Quanwei, Wan, Boheng, Wei, Ran, Wang, Yuchen, Zhang, Yanmin, Kong, Bo, Huang, Jianhang, Chen, Yadong, Lu, Tao, Hu, Qinghua, Du, Ding. Structure-based discovery of 1H-indole-2-carboxamide derivatives as potent ASK1 inhibitors for potential treatment of ulcerative colitis. European journal of medicinal chemistry, vol.211, 113114-.

  12. Harrison, Stephen A., Wong, Vincent Wai-Sun, Okanoue, Takeshi, Bzowej, Natalie, Vuppalanchi, Raj, Younes, Ziad, Kohli, Anita, Sarin, Shiv, Caldwell, Stephen H., Alkhouri, Naim, Shiffman, Mitchell L., Camargo, Marianne, Li, Georgia, Kersey, Kathryn, Jia, Catherine, Zhu, Yanni, Djedjos, C. Stephen, Subramanian, G. Mani, Myers, Robert P., Gunn, Nadege, Sheikh, Aasim, Anstee, Quentin M., Romero-Gomez, Manuel, Trauner, Michael, Goodman, Zachary, Lawitz, Eric J., Younossi, Zobair. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.73, no.1, 26-39.

  13. Loomba, Rohit, Lawitz, Eric, Mantry, Parvez S., Jayakumar, Saumya, Caldwell, Stephen H., Arnold, Hays, Diehl, Anna Mae, Djedjos, C. Stephen, Han, Ling, Myers, Robert P., Subramanian, G. Mani, McHutchison, John G., Goodman, Zachary D., Afdhal, Nezam H., Charlton, Michael R.. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.67, no.2, 549-559.

  14. Clinical trials searched drug name “selonsertib”. URLhttps://clinicaltrials.gov/(accessed January 7 2021). 

  15. Terao, Y., Suzuki, H., Yoshikawa, M., Yashiro, H., Takekawa, S., Fujitani, Y., Okada, K., Inoue, Y., Yamamoto, Y., Nakagawa, H., Yao, S., Kawamoto, T., Uchikawa, O.. Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors. Bioorganic & medicinal chemistry letters, vol.22, no.24, 7326-7329.

  16. N.Sakaiet al. (Takeda Pharmaceutical Company Limited) WO 2008/016192. 

  17. The biochemical activities against ASK1 were tested using the Eurofins Kinase Profiler screening platform (Eurofins Pharma Discovery Services UK Limited Dundee UK). In the assay ASK1 (h) is incubated with 8 mM MOPS pH 7.0 0.2 mM EDTA 0.33 mg/mL myelin basic protein 10 mM MgAcetate and [gamma‐33P]‐ATP. The reaction is initiated by the addition of the Mg/ATP mix. After incubation for 40 minutes at room temperature the reaction is stopped by the addition of phosphoric acid to a concentration of 0.5%. 10 μL of the reaction is then spotted onto a P30 filtermat and washed four times for 4 min in 0.425% phosphoric acid and once in methanol prior to drying and scintillation counting. 

  18. Schrödinger Release 2020‐4: Maestro 2020 

  19. Gomez-Lechon, M.J., Donato, M.T., Martinez-Romero, A., Jimenez, N., Castell, J.V., O'Connor, J.E.. A human hepatocellular in vitro model to investigate steatosis. Chemico-biological interactions, vol.165, no.2, 106-116.

  20. Cellular TG content measurement.Human hepatoma cell line HepG2 (Korean Cell Line Bank Seoul Korea) were cultured in Minimal Essential Medium (MEM; HyClone Logan UT USA) with 10% fetal bovine serum (HyClone Logan UT USA) 1% antibiotic‐antimycotic solution (HyClone Logan UT USA) at 37°C and 5% CO2. Cells were incubated in a 96‐well plate at a density of 2 × 104cells/well for 24 h. Then cells were treated with compounds and/or the mixture of palmitic acid and oleic acid at a ratio of 1:2 that was incubated in water bath at 70°C for 30 min. After 2‐day incubation the cellular TG content was measured using Triglyceride Quantification Kit (Sigma‐Aldrich St. Louis MO USA). 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로